About
Neumora is dedicated to addressing global brain health challenges by pioneering new approaches to drug development. The company focuses on neuropsychiatric disorders and neurodegenerative diseases through a precision neuroscience approach, aiming to redefine the standard of care with novel therapies that improve patient outcomes. With a pipeline of seven clinical and preclinical programs targeting unique mechanisms of action, Neumora is committed to transforming treatments for millions affected by these conditions.
